BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9696034)

  • 1. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
    Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
    Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
    Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
    Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression in human gestational trophoblastic tumors.
    Li F; Shao Z; Cang W; Qian N
    Chin Med J (Engl); 1998 Apr; 111(4):379-80. PubMed ID: 10374410
    [No Abstract]   [Full Text] [Related]  

  • 6. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
    Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
    Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
    Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous regression in choriocarcinoma and related gestational trophobalstic neoplasms.
    Hertz R
    Natl Cancer Inst Monogr; 1976 Nov; 44():59-60. PubMed ID: 193022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
    Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
    Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mitochondrial gene expression in human gestational trophoblastic diseases.
    Durand S; Dumur C; Flury A; Abadie P; Patrito L; Podhajcer O; Genti-Raimondi S
    Placenta; 2001; 22(2-3):220-6. PubMed ID: 11170827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of laminin and laminin receptor in gestational trophoblastic tumor and its significance].
    An RF; Wang S; Zhang YA; Bai XQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):344-6, 350. PubMed ID: 15931864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic studies on trophoblastic neoplasms].
    Huang SY; Song HZ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):383-6. PubMed ID: 1666547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic factors in gestational trophoblastic tumors].
    Flici O; Tadjerouni A; Robyn C
    Rev Med Brux; 1983 Jun; 4(6):417-20. PubMed ID: 6308743
    [No Abstract]   [Full Text] [Related]  

  • 19. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
    Ding F; Zhang QS; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
    Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
    J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.